id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2026-0133-0001,DEA,DEA-2026-0133,Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I,Proposed Rule,,2026-01-20T05:00:00Z,2026,1,2026-01-20T05:00:00Z,,2026-01-20T23:36:31Z,2026-00954,0,0,09000064b916130f
DEA-2026-0133-0004,DEA,DEA-2026-0133,DEA-1442 HHS Letter to DEA 06112025,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-01-20T23:39:08Z,,0,0,09000064b9162339
DEA-2026-0133-0003,DEA,DEA-2026-0133,DEA-1442 DEA Letter to HHS 11012024,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-02-12T21:01:03Z,,0,1,09000064b9162338
DEA-2026-0133-0002,DEA,DEA-2026-0133,DEA-1442 3-Factor Analysis 2-Fluorodeschloroketamine January 2026,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-01-20T23:39:02Z,,0,0,09000064b9162337
DEA-2026-0133-0005,DEA,DEA-2026-0133,DEA-1442 HHS Letter to DEA 11082024,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-01-20T23:39:10Z,,0,0,09000064b916233a
DEA-2026-0133-0006,DEA,DEA-2026-0133,DEA-1442 DEA Letter to HHS 05282025,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-02-12T21:01:51Z,,0,1,09000064b916233b